Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pricing strategy
Money
75 per cent or more of a practices' profits are generated by drug sales as opposed to professional fees.

Falling client numbers, competition, and the internet all threaten consumable sales

The pricing strategy is the means by which a business calculates how much it will charge for its products and services, and it determines the business's profit.  

Profit was the theme of Alan Robinson's lecture during the Management Session at BSAVA Congress.
 
Alan explained that veterinary practice actually consists of three businesses and each has a different pricing strategy:

1. Clinical services that are time-based with high fixed costs and are therefore high cost and low volume
 
2. Preventative health care  - a high volume low value service which requires very competitive pricing
 
3. Retail business, which has 3 mark-ups applied to most products: the percentage mark up to the list price cost of products, the premium pricing mark-ups applied to list price, and the fixed mark up which is the dispensing/injection fee.

75 per cent or more of a practices' profits are generated by drug sales as opposed to professional fees and, in some cases, the retail sales totally subsidise the clinical services provided by the practice.

Falling client numbers, more competition, The Marsh Report, and the internet all threaten consumable sales. In today's climate, clients are far more likely to compare pricing against their current source, challenge practices to match or reduce prices to online level and switch to sourcing products online. Similalry, clients far more commonly compare their vet's knowledge with veterinary information they have taken from online sources, meaning that, as Alan said, ' vets are no longer the purveyors of information but the curators.'

The result of all of these factors is that veterinary practices are losing profit and also the goodwill of clients.

At the same time, drug inflation is at 5.1 per cent and the general economic climate is poor. This leads to veterinary expenses being an increasing percentage of clients income - hardly surprising then that pet owners will search online for better deals.

The answer, says Alan, is not for practices to try to compete with the online pharmacies -  which have low cost, high volume, deep pockets and thin margins. Practices have high cost, low volume, small pockets and thin margins!
New and mixed pricing strategies are required with proactive pricing in line with online pharmacies. On key ranges, not price matching.

Alan suggested that having variable mark-ups was a good strategy, but to do this practices need to understand true net costs, not just list prices and competitor pricing.

Profit expectations need to be re-evaluated and differentiation in pricing for same product between short and long-term medication considered so that the price of the drug used for short term treatment would be higher than the cost of the same drug used for long term medication.

The future may well bring reduced pricing and profitability in some areas and drug ranges, but the benefits will be the retention of client goodwill.
 

Become a member or log in to add this story to your CPD history

Prof Joanne Webster elected as Fellow of the Royal Society

News Story 1
 Joanne Webster, a professor of parasitic diseases at the RVC, has been elected as a Fellow of the Royal Society (FRS).

An infectious disease expert, Prof Webster is known for promoting a One Health approach to disease control.

She completed her doctoral research in zoonotic disease and parasite-host interactions, and has since earned widespread recognition for contributions to parasitology and global health.

Prof Webster said: "I am truly honoured, and somewhat stunned, to be recognised alongside such an exceptional group of scientists." 

Click here for more...
News Shorts
Germany FMD import restrictions eased

The UK government has lifted the import restrictions placed on FMD-susceptible commodities from Germany.

The decision comes after the country was recognised as foot-and-mouth disease free without vaccination on 14 May.

Imports of FMD-susceptible animals and their by-products from Germany were originally banned, after the country reported a case of FMD near Brandenburg in January. In March, the UK government permitted imports from outside of the outbreak zone.

Germany will now be able to import FMD-susceptible animals and their by-products into the UK, providing they meet other import conditions.

The decision follows rigorous technical assessment of measures in Germany. Defra says it will not hesitate respond to FMD outbreaks.